GB1556569A - 1,5-disubstituted - 2 - pyrrolidones - Google Patents
1,5-disubstituted - 2 - pyrrolidonesInfo
- Publication number
- GB1556569A GB1556569A GB33002/77A GB3300277A GB1556569A GB 1556569 A GB1556569 A GB 1556569A GB 33002/77 A GB33002/77 A GB 33002/77A GB 3300277 A GB3300277 A GB 3300277A GB 1556569 A GB1556569 A GB 1556569A
- Authority
- GB
- United Kingdom
- Prior art keywords
- pyrrolidones
- disubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71236276A | 1976-08-06 | 1976-08-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1556569A true GB1556569A (en) | 1979-11-28 |
Family
ID=24861795
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB33002/77A Expired GB1556569A (en) | 1976-08-06 | 1977-08-05 | 1,5-disubstituted - 2 - pyrrolidones |
GB43588/78A Expired GB1556570A (en) | 1976-08-06 | 1977-08-05 | 1,5-disubstituted - 2 - pyrrolidones |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB43588/78A Expired GB1556570A (en) | 1976-08-06 | 1977-08-05 | 1,5-disubstituted - 2 - pyrrolidones |
Country Status (31)
Country | Link |
---|---|
JP (2) | JPS5321159A (cs) |
AR (1) | AR217080A1 (cs) |
AT (1) | AT362887B (cs) |
AU (1) | AU508007B2 (cs) |
BE (1) | BE857506A (cs) |
BG (1) | BG31073A3 (cs) |
CA (1) | CA1077948A (cs) |
CH (1) | CH624934A5 (cs) |
CS (1) | CS221269B2 (cs) |
DD (2) | DD143768A5 (cs) |
DE (1) | DE2735904A1 (cs) |
DK (1) | DK352077A (cs) |
ES (2) | ES461388A1 (cs) |
FI (1) | FI70009C (cs) |
FR (1) | FR2369260A1 (cs) |
GB (2) | GB1556569A (cs) |
GR (1) | GR68688B (cs) |
HU (1) | HU180273B (cs) |
IE (1) | IE45505B1 (cs) |
IL (1) | IL52615A (cs) |
LU (1) | LU77936A1 (cs) |
NL (1) | NL7708637A (cs) |
NO (1) | NO772752L (cs) |
NZ (1) | NZ184806A (cs) |
PH (1) | PH17398A (cs) |
PL (2) | PL112931B1 (cs) |
PT (1) | PT66891B (cs) |
SE (1) | SE423813B (cs) |
SU (3) | SU703016A3 (cs) |
YU (1) | YU192577A (cs) |
ZA (1) | ZA774704B (cs) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1132086A2 (en) * | 2000-01-31 | 2001-09-12 | Pfizer Products Inc. | Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure |
WO2003077910A1 (en) * | 2002-03-18 | 2003-09-25 | Pfizer Products Inc. | Methods of treatment with selective ep4 receptor agonists |
EP1586564A1 (en) * | 2003-01-21 | 2005-10-19 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivatives and medicinal uses thereof |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5695569A (en) * | 1979-12-27 | 1981-08-03 | Canon Inc | Forming method for bar lens sphere face |
US4321201A (en) * | 1980-09-22 | 1982-03-23 | E. I. Du Pont De Nemours And Company | Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates |
JPS59137224A (ja) * | 1983-01-25 | 1984-08-07 | Mitsubishi Electric Corp | 電気鉄道用き電電圧補償装置 |
AU2001290250A1 (en) * | 2000-09-21 | 2002-04-02 | Ono Pharmaceutical Co. Ltd. | Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
KR20030053063A (ko) * | 2000-11-27 | 2003-06-27 | 화이자 프로덕츠 인코포레이티드 | 골다공증 치료용 이피4 수용체 선택성 작용제 |
PL367740A1 (en) * | 2001-07-23 | 2005-03-07 | Ono Pharmaceutical Co, Ltd. | Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient |
US6573294B1 (en) * | 2002-05-14 | 2003-06-03 | Allergan, Inc. | 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1386146A (en) * | 1972-05-03 | 1975-03-05 | Ici Ltd | Cyclopentane derivatives |
JPS511460A (en) * | 1974-06-24 | 1976-01-08 | Tanabe Seiyaku Co | 22 piroridonjudotaino seiho |
JPS514166A (ja) * | 1974-06-28 | 1976-01-14 | Tanabe Seiyaku Co | 22piroridonjudotaino seiho |
US3975399A (en) * | 1974-08-06 | 1976-08-17 | E. I. Du Pont De Nemours And Company | 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones |
DE2528664A1 (de) * | 1975-06-27 | 1977-01-13 | Hoechst Ag | Pyrrolidone und verfahren zu ihrer herstellung |
-
1977
- 1977-07-27 CA CA283,598A patent/CA1077948A/en not_active Expired
- 1977-07-27 SE SE7708642A patent/SE423813B/xx unknown
- 1977-07-28 IL IL52615A patent/IL52615A/xx unknown
- 1977-07-28 GR GR54058A patent/GR68688B/el unknown
- 1977-08-01 AU AU27515/77A patent/AU508007B2/en not_active Expired
- 1977-08-02 PH PH20060A patent/PH17398A/en unknown
- 1977-08-02 NZ NZ184806A patent/NZ184806A/xx unknown
- 1977-08-04 NL NL7708637A patent/NL7708637A/xx not_active Application Discontinuation
- 1977-08-04 ZA ZA00774704A patent/ZA774704B/xx unknown
- 1977-08-04 PT PT66891A patent/PT66891B/pt unknown
- 1977-08-05 FR FR7724290A patent/FR2369260A1/fr active Granted
- 1977-08-05 LU LU77936A patent/LU77936A1/xx unknown
- 1977-08-05 HU HU77PI587A patent/HU180273B/hu unknown
- 1977-08-05 SU SU772511155A patent/SU703016A3/ru active
- 1977-08-05 DE DE19772735904 patent/DE2735904A1/de not_active Ceased
- 1977-08-05 CS CS775202A patent/CS221269B2/cs unknown
- 1977-08-05 DD DD77213369A patent/DD143768A5/de unknown
- 1977-08-05 BG BG037109A patent/BG31073A3/xx unknown
- 1977-08-05 GB GB33002/77A patent/GB1556569A/en not_active Expired
- 1977-08-05 BE BE1008318A patent/BE857506A/xx not_active IP Right Cessation
- 1977-08-05 ES ES461388A patent/ES461388A1/es not_active Expired
- 1977-08-05 IE IE1641/77A patent/IE45505B1/en unknown
- 1977-08-05 GB GB43588/78A patent/GB1556570A/en not_active Expired
- 1977-08-05 DK DK352077A patent/DK352077A/da not_active Application Discontinuation
- 1977-08-05 CH CH964677A patent/CH624934A5/fr not_active IP Right Cessation
- 1977-08-05 FI FI772376A patent/FI70009C/fi not_active IP Right Cessation
- 1977-08-05 YU YU01925/77A patent/YU192577A/xx unknown
- 1977-08-05 NO NO772752A patent/NO772752L/no unknown
- 1977-08-05 DD DD77200468A patent/DD136135A5/xx unknown
- 1977-08-05 AR AR268699A patent/AR217080A1/es active
- 1977-08-06 JP JP9458977A patent/JPS5321159A/ja active Granted
- 1977-08-08 AT AT0579477A patent/AT362887B/de not_active IP Right Cessation
- 1977-08-08 PL PL1977215666A patent/PL112931B1/pl unknown
- 1977-08-08 PL PL77200124A patent/PL200124A1/xx unknown
-
1978
- 1978-07-01 ES ES471349A patent/ES471349A1/es not_active Expired
- 1978-10-11 SU SU782672200A patent/SU818480A3/ru active
- 1978-10-17 SU SU782674602A patent/SU850000A3/ru active
-
1979
- 1979-09-03 JP JP54112743A patent/JPS585196B2/ja not_active Expired
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1132086A2 (en) * | 2000-01-31 | 2001-09-12 | Pfizer Products Inc. | Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure |
EP1132086A3 (en) * | 2000-01-31 | 2002-01-09 | Pfizer Products Inc. | Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure |
US6610719B2 (en) | 2000-01-31 | 2003-08-26 | Pfizer Inc. | Use of prostaglandin (PGE2) receptor a (EP4) selective agonists for the treatment of acute and chronic renal failure |
WO2003077910A1 (en) * | 2002-03-18 | 2003-09-25 | Pfizer Products Inc. | Methods of treatment with selective ep4 receptor agonists |
EP1586564A1 (en) * | 2003-01-21 | 2005-10-19 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivatives and medicinal uses thereof |
EP1586564A4 (en) * | 2003-01-21 | 2008-04-30 | Ono Pharmaceutical Co | 8-AZAPROSTAGLANDIN DERIVATIVES AND THEIR MEDICAL USE |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH13932A (en) | 1,2,3,4-tetrahydro-napthalenes | |
ZA77587B (en) | 2-piperazinyl-6,7-dimethoxyquinazolines | |
GB1524917A (en) | Gona-1,9(10)-dienes | |
NZ183143A (en) | 2-aminoakyl-1,2-benzisothiazol 3-anes | |
GB1542361A (en) | 1,4-benzo-dioxan derivatives | |
GB1556569A (en) | 1,5-disubstituted - 2 - pyrrolidones | |
GB1542569A (en) | 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins | |
IL52424A0 (en) | 2,6-methano-2h-1-benzoxocins | |
AU2468877A (en) | 1,4 -dicyanobytene | |
PH14105A (en) | 1,2,3-thiadiazol-5-yl-ureas | |
ZA774515B (en) | O-ethyl-s-n-propyl-o-2,2,2-trihaloethylphosphorothiolates(or thionothiolates) | |
GB1537635A (en) | 15,16-dihydroxyprostaglandins | |
HK36785A (en) | 1-amino-alkyl-3,4-diphenyl-1h-pyrazoles | |
GB1538368A (en) | 1,3,4,6-tetrathia and tetraselena-2,5-dihetero-pentalene compounds | |
IL53527A0 (en) | N1-chloro-3,5-dinitrosulfanilamides | |
NZ184082A (en) | 1-benzothiazol-2yl-1,3-imidazolidin-2-ones | |
GB1554049A (en) | 2-decarboxy-2-hydroxymethyl-13,14-didehydroprostaglandins | |
GB1547729A (en) | 1-phenyl-4-acetoxy-1,2-dihydroquinolin-2-ones | |
GB1541820A (en) | 1,4-oxathianes | |
AU3178777A (en) | Substituted 4,5-dihydroxy-imidazolidine-2-thiones | |
CY1138A (en) | 2,3-dihydro-2-oxo-3-benzo(b)thiophenecarboxamides | |
GB1546347A (en) | 5,11-diazatetracyclo-(6.2.2.02,7 04,9)-dodecanes | |
ZA774088B (en) | 2,5-dichloro-4-bromphenylazo-4-chloro-phenyl-sulphide | |
GB1554045A (en) | 13,14-didehydroprostaglandins | |
PL187440A1 (en) | Sposob wytwarzania nowych pochodnych 3,4-dwuhydro-2h-1,3-benzoksazynotionu-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |